모세관 전기영동 시장 규모, 점유율, 성장 및 세계의 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of capillary electrophoresis (CE) Market

The global capillary electrophoresis (CE) market was valued at USD 438.75 million in 2025 and is projected to grow to USD 461.3 million in 2026, reaching USD 673.37 million by 2034, reflecting a CAGR of 4.84% during the forecast period. North America dominated the market in 2025 with a 38.05% share, amounting to USD 166.94 million, due to the region's strong research and development (R&D) activities and advanced clinical infrastructure.

Capillary electrophoresis is an analytical technique that separates ions and molecules based on size and charge in a capillary tube using a high-voltage electric field. Its applications include nucleic acid analysis, protein characterization, and clinical diagnostics. The market growth is fueled by increasing R&D initiatives by pharmaceutical and biotechnology companies and rising adoption of precision medicine.

Market Dynamics

Drivers

The increasing prevalence of chronic diseases such as cancer and genetic disorders, combined with the rising demand for precision medicine, is driving market growth. CE offers high-resolution, fast analytical capabilities, critical for disease diagnostics and personalized treatments. In January 2025, the American Cancer Society reported that approximately 18.6 million individuals in the U.S. were living with a history of cancer, a number expected to surpass 22 million by 2035. This rising patient population fuels CE adoption in clinical laboratories.

Restraints

High initial investment and running costs are limiting market expansion. Advanced CE systems range between USD 20,000 and USD 150,000, with additional operational costs for consumables and maintenance, restricting adoption in smaller labs and emerging markets.

Opportunities

Emerging markets and academic research present significant growth opportunities. Governments in Asia Pacific, Latin America, and Africa are investing in pharmaceutical and biotech R&D, creating demand for cost-efficient CE systems. Benchtop and compact CE instruments provide affordable entry points for laboratories, supporting expansion in these regions. Academic institutions are increasingly adopting CE for education and research, further boosting market potential.

Challenges

A shortage of skilled professionals is a key challenge. Operating CE instruments requires technical expertise in sample preparation, troubleshooting, and data analysis. In February 2023, the Journal of Scientific & Technical Research reported a shortage of approximately 25,000 medical technologists in the U.S., restricting effective utilization of advanced CE systems and slowing market growth, especially in developing countries.

Market Trends

Integration with mass spectrometry (CE-MS) is a key market trend. CE-MS enhances qualitative and quantitative analysis of biomolecules, metabolites, and peptides, critical in proteomics, metabolomics, and drug discovery. In June 2024, CMP Scientific launched the BioSummit CVA system, a next-generation CE-MS platform for high-precision protein analysis, reflecting rising adoption in biopharmaceutical research and clinical diagnostics.

Segmentation Analysis

By Product: The market is divided into instruments, consumables, and software. The consumables segment dominated in 2026 with a 58.53% share, driven by ongoing replacement needs for capillaries, buffers, reagents, and cartridges in academic, pharmaceutical, and biotechnology labs. Instruments, including automatic and semi-automatic CE systems, are projected to grow at a CAGR of 5.0%.

By Mode: Segments include capillary zone electrophoresis, capillary gel electrophoresis (CGE), and capillary electrochromatography. CGE led the market in 2025, accounting for a 43.97% share in 2026, primarily due to applications in nucleic acid and protein analysis. Capillary electrochromatography is projected to grow at a CAGR of 5.4%.

By Application: Segments include nucleic acid analysis, drug discovery, protein & peptide analysis, and clinical diagnostics. Nucleic acid analysis held the largest share in 2025, with a 30.4% share in 2026, driven by rapid expansion in DNA/RNA sequencing and genotyping. Protein & peptide analysis is expected to grow at 5.8% CAGR.

By End-user: Segments include academic & research institutes, pharmaceutical & biotechnology companies, clinical labs, and others. Academic & research institutes dominated in 2025, with a 41.36% share in 2026, supported by training initiatives such as the 2024 Sun Lab CE-MS summer school at Michigan State University. Pharmaceutical & biotechnology companies are projected to grow at 5.3% CAGR.

Regional Outlook

• North America led in 2025 with USD 166.94 million, growing to USD 175.63 million in 2026 due to strong R&D investments.
• Europe was valued at USD 121.1 million in 2025, driven by research institutions in the U.K., Germany, and France.
• Asia Pacific held USD 104.5 million in 2025, with India at USD 10.49 million and China at USD 53.45 million in 2026, showing rapid adoption.
• Latin America and Middle East & Africa were valued at USD 18.3 million and USD 9.9 million respectively in 2025, with moderate growth projected.

Competitive Landscape

The market is led by Thermo Fisher Scientific, Agilent Technologies, Danaher, Helena Laboratories, QIAGEN, Bio-Rad, Bio-Techne, PerkinElmer, Merck KGaA, and Shimadzu Corporation. Key developments include Thermo Fisher's 2025 launch of the SeqStudio Flex Dx Genetic Analyzer, and Agilent's 2024 ProteoAnalyzer system for protein analysis. Companies focus on product innovation and global expansion to strengthen their market presence.

Conclusion

The global capillary electrophoresis market, valued at USD 438.75 million in 2025, is projected to reach USD 461.3 million in 2026 and USD 673.37 million by 2034, at a CAGR of 4.84%. Growth is driven by rising chronic disease prevalence, adoption of precision medicine, expanding academic research, and integration with mass spectrometry. While high costs and skilled labor shortages pose challenges, opportunities in emerging markets and continuous technological advancements are expected to support sustained market expansion through 2034.

Segmentation By Product, Mode, Application, End-user, and Region

By Product * Instruments

• Automatic Capillary Electrophoresis Systems
• Semi-Automatic Capillary Electrophoresis Systems
• Consumables
• Software

By Mode * Capillary Zone Electrophoresis

• Capillary Gel Electrophoresis
• Capillary Electrochromatography
• Others

By Application * Nucleic Acid Analysis

• Drug Discovery & Development
• Protein & Peptide Analysis
• Clinical Diagnostics
• Others

By End-user * Pharmaceutical & Biotechnology Companies

• Academic & Research Institutes
• Clinical Laboratories
• Others

By Geography * North America (By Product, Mode, Application, End-user, and Country)

• U.S. (Product)
• Canada (Product)
• Europe (By Product, Mode, Application, End-user, and Country/Sub-region)
  • Germany (Product)
  • U.K. (Product)
  • France (Product)
  • Spain (Product)
  • Italy (Product)
  • Scandinavia (Product)
  • Rest of Europe (Product)
• Asia Pacific (By Product, Mode, Application, End-user, and Country/Sub-region)
  • China (Product)
  • Japan (Product)
  • India (Product)
  • Australia (Product)
  • Southeast Asia (Product)
  • Rest of Asia Pacific (Product)
• Latin America (By Product, Mode, Application, End-user, and Country/Sub-region)
  • Brazil (Product)
  • Mexico (Product)
  • Rest of Latin America (Product)
• Middle East & Africa (By Product, Mode, Application, End-user, and Country/Sub-region)
  • GCC (Product)
  • South Africa (Product)
  • Rest of the Middle East & Africa (Product)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. New Product Launches, By Key Players
• 4.2. Key Industry Developments (Mergers, Acquisitions, and Partnerships, among others)
• 4.3. Technological Advancements in Capillary Electrophoresis Systems

5. Global Capillary Electrophoresis Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Product
  • 5.1.1. Instruments
    • 5.1.1.1. Automatic Capillary Electrophoresis Systems
    • 5.1.1.2. Semi-Automatic Capillary Electrophoresis Systems
  • 5.1.2. Consumables
  • 5.1.3. Software
• 5.2. Market Analysis, Insights and Forecast - By Mode
  • 5.2.1. Capillary Zone Electrophoresis
  • 5.2.2. Capillary Gel Electrophoresis
  • 5.2.3. Capillary Electrochromatography
  • 5.2.4. Others
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Nucleic Acid Analysis
  • 5.3.2. Drug Discovery & Development
  • 5.3.3. Protein & Peptide Analysis
  • 5.3.4. Clinical Diagnostics
  • 5.3.5. Others
• 5.4. Market Analysis, Insights and Forecast - By End-user
  • 5.4.1. Pharmaceutical & Biotechnology Companies
  • 5.4.2. Academic & Research Institutes
  • 5.4.3. Clinical Laboratories
  • 5.4.4. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Capillary Electrophoresis Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Product
  • 6.1.1. Instruments
    • 6.1.1.1. Automatic Capillary Electrophoresis Systems
    • 6.1.1.2. Semi-Automatic Capillary Electrophoresis Systems
  • 6.1.2. Consumables
  • 6.1.3. Software
• 6.2. Market Analysis, Insights and Forecast - By Mode
  • 6.2.1. Capillary Zone Electrophoresis
  • 6.2.2. Capillary Gel Electrophoresis
  • 6.2.3. Capillary Electrochromatography
  • 6.2.4. Others
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Nucleic Acid Analysis
  • 6.3.2. Drug Discovery & Development
  • 6.3.3. Protein & Peptide Analysis
  • 6.3.4. Clinical Diagnostics
  • 6.3.5. Others
• 6.4. Market Analysis, Insights and Forecast - By End-user
  • 6.4.1. Pharmaceutical & Biotechnology Companies
  • 6.4.2. Academic & Research Institutes
  • 6.4.3. Clinical Laboratories
  • 6.4.4. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
    • 6.5.1.1. By Product
  • 6.5.2. Canada
    • 6.5.2.1. By Product

7. Europe Capillary Electrophoresis Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Product
  • 7.1.1. Instruments
    • 7.1.1.1. Automatic Capillary Electrophoresis Systems
    • 7.1.1.2. Semi-Automatic Capillary Electrophoresis Systems
  • 7.1.2. Consumables
  • 7.1.3. Software
• 7.2. Market Analysis, Insights and Forecast - By Mode
  • 7.2.1. Capillary Zone Electrophoresis
  • 7.2.2. Capillary Gel Electrophoresis
  • 7.2.3. Capillary Electrochromatography
  • 7.2.4. Others
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Nucleic Acid Analysis
  • 7.3.2. Drug Discovery & Development
  • 7.3.3. Protein & Peptide Analysis
  • 7.3.4. Clinical Diagnostics
  • 7.3.5. Others
• 7.4. Market Analysis, Insights and Forecast - By End-user
  • 7.4.1. Pharmaceutical & Biotechnology Companies
  • 7.4.2. Academic & Research Institutes
  • 7.4.3. Clinical Laboratories
  • 7.4.4. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.5.1. U.K.
    • 7.5.1.1. By Product
  • 7.5.2. Germany
    • 7.5.2.1. By Product
  • 7.5.3. France
    • 7.5.3.1. By Product
  • 7.5.4. Spain
    • 7.5.4.1. By Product
  • 7.5.5. Italy
    • 7.5.5.1. By Product
  • 7.5.6. Scandinavia
    • 7.5.6.1. By Product
  • 7.5.7. Rest of Europe
    • 7.5.7.1. By Product

8. Asia Pacific Capillary Electrophoresis Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Product
  • 8.1.1. Instruments
    • 8.1.1.1. Automatic Capillary Electrophoresis Systems
    • 8.1.1.2. Semi-Automatic Capillary Electrophoresis Systems
  • 8.1.2. Consumables
  • 8.1.3. Software
• 8.2. Market Analysis, Insights and Forecast - By Mode
  • 8.2.1. Capillary Zone Electrophoresis
  • 8.2.2. Capillary Gel Electrophoresis
  • 8.2.3. Capillary Electrochromatography
  • 8.2.4. Others
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Nucleic Acid Analysis
  • 8.3.2. Drug Discovery & Development
  • 8.3.3. Protein & Peptide Analysis
  • 8.3.4. Clinical Diagnostics
  • 8.3.5. Others
• 8.4. Market Analysis, Insights and Forecast - By End-user
  • 8.4.1. Pharmaceutical & Biotechnology Companies
  • 8.4.2. Academic & Research Institutes
  • 8.4.3. Clinical Laboratories
  • 8.4.4. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
    • 8.5.1.1. By Product
  • 8.5.2. China
    • 8.5.2.1. By Product
  • 8.5.3. Australia
    • 8.5.3.1. By Product
  • 8.5.4. India
    • 8.5.4.1. By Product
  • 8.5.5. Southeast Asia
    • 8.5.5.1. By Product
  • 8.5.6. Rest of Asia Pacific
    • 8.5.6.1. By Product

9. Latin America Capillary Electrophoresis Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Product
  • 9.1.1. Instruments
    • 9.1.1.1. Automatic Capillary Electrophoresis Systems
    • 9.1.1.2. Semi-Automatic Capillary Electrophoresis Systems
  • 9.1.2. Consumables
  • 9.1.3. Software
• 9.2. Market Analysis, Insights and Forecast - By Mode
  • 9.2.1. Capillary Zone Electrophoresis
  • 9.2.2. Capillary Gel Electrophoresis
  • 9.2.3. Capillary Electrochromatography
  • 9.2.4. Others
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Nucleic Acid Analysis
  • 9.3.2. Drug Discovery & Development
  • 9.3.3. Protein & Peptide Analysis
  • 9.3.4. Clinical Diagnostics
  • 9.3.5. Others
• 9.4. Market Analysis, Insights and Forecast - By End-user
  • 9.4.1. Pharmaceutical & Biotechnology Companies
  • 9.4.2. Academic & Research Institutes
  • 9.4.3. Clinical Laboratories
  • 9.4.4. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
    • 9.5.1.1. By Product
  • 9.5.2. Mexico
    • 9.5.2.1. By Product
  • 9.5.3. Rest of Latin America
    • 9.5.3.1. By Product

10. Middle East & Africa Capillary Electrophoresis Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Product
  • 10.1.1. Instruments
    • 10.1.1.1. Automatic Capillary Electrophoresis Systems
    • 10.1.1.2. Semi-Automatic Capillary Electrophoresis Systems
  • 10.1.2. Consumables
  • 10.1.3. Software
• 10.2. Market Analysis, Insights and Forecast - By Mode
  • 10.2.1. Capillary Zone Electrophoresis
  • 10.2.2. Capillary Gel Electrophoresis
  • 10.2.3. Capillary Electrochromatography
  • 10.2.4. Others
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Nucleic Acid Analysis
  • 10.3.2. Drug Discovery & Development
  • 10.3.3. Protein & Peptide Analysis
  • 10.3.4. Clinical Diagnostics
  • 10.3.5. Others
• 10.4. Market Analysis, Insights and Forecast - By End-user
  • 10.4.1. Pharmaceutical & Biotechnology Companies
  • 10.4.2. Academic & Research Institutes
  • 10.4.3. Clinical Laboratories
  • 10.4.4. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. South Africa
    • 10.5.1.1. By Product
  • 10.5.2. GCC
    • 10.5.2.1. By Product
  • 10.5.3. Rest of the Middle East & Africa
    • 10.5.3.1. By Product

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2026)
• 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  • 11.2.1. Danaher
  • 11.2.2. Helena Laboratories Corporation
  • 11.2.3. QIAGEN
  • 11.2.4. Thermo Fisher Scientific Inc.
  • 11.2.5. Agilent Technologies Inc.
  • 11.2.6. Bio-Rad Laboratories Inc.
  • 11.2.7. Bio-Techne
  • 11.2.8. PerkinElmer Inc.
  • 11.2.9. Merck KGaA
  • 11.2.10. Shimadzu Corporation